ATC Group: C08DA01 Verapamil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C08DA01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C08 Calcium channel blockers
3 C08D Selective calcium channel blockers with direct cardiac effects
4 C08DA Phenylalkylamine derivatives
5 C08DA01 Verapamil

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.24 g
PAREN - Parenteral 0.24 g

Active ingredients in C08DA01

Active Ingredient Description
Verapamil

Verapamil is a phenylalkylamine calcium antagonist which blocks the inward movement of calcium ions in cardiac muscle cells, in smooth muscle cells of the coronary and systemic arteries and in cells of the intracardiac conduction system. It lowers heart rate, increases myocardial perfusion and reduces coronary spasm. Because of its effect on the movement of calcium in the intracardiac conduction system, verapamil reduces automaticity, decreases conduction velocity and increases the refractory period.

Related product monographs

Title Information Source Document Type  
AKILEN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ISOPTIN Film‐coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
ISOPTIN Solution for injection / infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC
SECURON Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SECURON SR Modified-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VERAPAMIL Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.